Glutamate cysteine ligase as a diagnostic biomarker and therapeutic target in Parkinson's disease: a multi omics and experimental study European Journal of Medical Research Springer Nature Link Glutathione Depletion and Concomitant Elevation of Susceptibility in Patients with Parkinson's Disease: State of the Art MR Spectroscopy and Neuropsychological Study ScienceDirect Parkinson's disease specific Synuclein variants potentially drive Lewy body formation by engaging in promiscuous and non functional interactions Communications Biology Higher'dose glutathione therapy for Parkinson's disease in Japan: Is it really safe?